Renal Cell Carcinoma (RCC): Current Approach to First Line Therapy and Beyond
0% Complete
Course Overview
NA
Course Content
Course Details
- Duration
- 0.00 hour
- Released
- May 14, 2025
- Last Review
- May 14, 2025
- Expires
- May 14, 2028
Objectives
NA
Target Audience
NA
Faculty & Disclosure
Faculty
Petros Grivas, MD, PhD
Disclosure
Petros Grivas, MD, PhD discloses no such relationships exist
Accreditation
NA
-1765651128502.webp&w=3840&q=75)
-1750794499192.webp&w=3840&q=75)